399 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Flip the Script: Drugmakers Blame Middlemen for Price Increases https://www.wsj.com/articles/flip-the-script-drugmakers-blame-middlemen-for-price-hikes-11549364401?mod=pls_whats_news_us_business_f Feb 05, 2019 - Under pressure over rising drug prices, pharmaceutical companies are pushing a new defense: They’re not raising prices to make money or to cover research costs, but rather to pay a cut to middlemen in the supply chain.
Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2018 http://www.gurufocus.com/news/817582/allergan-plc-agn-files-10k-for-the-fiscal-year-ended-on-december-31-2018 Feb 15, 2019 - Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2018, Stocks: AGN, release date:Feb 15, 2019
2 Frustrating Flops, Plus Welcome to the Wrinkle Wars https://www.fool.com/investing/2019/02/21/2-frustrating-flops-plus-welcome-to-the-wrinkle-wa.aspx?source=iedfolrf0000001 Feb 21, 2019 - Disappointing data from Gilead Sciences and Sangamo weigh on investors, while one tiny stock challenges Allergan.
Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle? https://www.fool.com/investing/2019/03/19/starboard-vs-bristol-myers-squibb-and-celgene-whol.aspx?source=iedfolrf0000001 Mar 19, 2019 - An activist investor made a strong argument for walking away from Celgene, but will investors listen?
Allergan PLC (AGN) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/07/allergan-plc-agn-q1-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 May 07, 2019 - AGN earnings call for the period ending May 7, 2019.
Allergan Plc (AGN) CEO Brent Saunders on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4261019-allergan-plc-agn-ceo-brent-saunders-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 07, 2019 - Allergan Plc (NYSE:AGN) Q1 2019 Earnings Conference Call May 07, 2019 08:30 AM ET Company Participants Manisha Narasimhan - Vice President of Investor Relations and Strategic Initiatives Brent Saunder
How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks? https://www.fool.com/investing/2019/09/05/how-will-johnson-johnsons-opioid-case-ruling-impac.aspx?source=iedfolrf0000001 Sep 05, 2019 - Investors need to be careful about which pharmaceutical stocks they own.
Festival honors former Quiksilver CEO Pierre Agnes, lost at sea in 2018 https://www.ocregister.com/2019/10/29/festival-honors-former-quiksilver-ceo-pierre-agnes-lost-at-sea-in-2018/ Oct 29, 2019 - Agnes disappeared during a storm while sailing off the coast of his native France.
AbbVie Lays Out Plans to Integrate Allergan https://www.fool.com/investing/2020/01/08/abbvie-lays-out-plans-to-integrate-allergan.aspx?source=iedfolrf0000001 Jan 08, 2020 - The company is leaving the aesthetics unit largely intact.
Allergan Reports Fourth-Quarter 2019 Results That Plow Past Expectations https://www.fool.com/investing/2020/02/10/allergan-reports-fourth-quarter-2019-results-that.aspx?source=iedfolrf0000001 Feb 10, 2020 - The maker of Botox appears to be on an upswing just ahead of its megamerger with AbbVie.

Pages: 1...678910111213141516...40

<<<Page 11>